Teleflex Incorporated (TFX)

NYSE
Currency in USD
177.68
-1.50(-0.83%)
Real-time Data
TFX Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
176.97181.85
52 wk Range
171.69256.85
Key Statistics
Edit
Prev. Close
179.17
Open
179.99
Day's Range
176.97-181.85
52 wk Range
171.69-256.85
Volume
114.95K
Average Volume (3m)
463.29K
1-Year Change
-28.09%
Book Value / Share
95.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TFX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
236.59
Upside
+33.16%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Teleflex Incorporated Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated SWOT Analysis


Financial Resilience
Teleflex demonstrates adaptability amidst challenges, adjusting guidance while maintaining profitability through effective cost management and strategic initiatives
Market Dynamics
Explore Teleflex's navigation of complex market forces, from unexpected customer losses to promising growth in key segments like Intra-Aortic Balloon Pumps
Strategic Vision
Delve into Teleflex's growth strategy, combining organic expansion with strategic acquisitions to strengthen market position and drive innovation
Analyst Outlook
Price targets range from $210 to $285, reflecting varied optimism about Teleflex's future prospects and ability to overcome current headwinds
Read full SWOT analysis

Teleflex Incorporated Earnings Call Summary for Q3/2024

  • Teleflex Q3 revenue up 2.4% to $764.4M, adjusted EPS down 4.1% to $3.49; raises full-year guidance despite mixed results
  • Company initiates $500M share repurchase program; adjusts Interventional Urology growth expectations due to UroLift challenges
  • Adjusted gross margin improves to 60.8%; year-to-date cash flow from operations at $435.6M
  • Full-year adjusted constant currency revenue growth projected at 3.5-4%; EPS outlook raised to $13.90-$14.20
  • Strategic acquisitions and product growth in Interventional Urology and Vascular Access drive improved outlook
Last Updated: 2024-11-01, 09:22 a/m
Read Full Transcript

Compare TFX to Peers and Sector

Metrics to compare
TFX
Peers
Sector
Relationship
P/E Ratio
34.6x35.8x−0.6x
PEG Ratio
−0.851.830.00
Price/Book
1.8x5.6x2.6x
Price / LTM Sales
2.7x6.5x3.1x
Upside (Analyst Target)
28.1%26.9%55.2%
Fair Value Upside
Unlock2.2%9.8%Unlock

Analyst Ratings

5 Buy
9 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 236.59

(+33.16% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.05
Dividend Yield
0.76%
Industry Median 0.72%
Annualized payout
1.3600
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 31, 2024
EPS / Forecast
3.49 / 3.39
Revenue / Forecast
764.40M / 768.68M
EPS Revisions
Last 90 days

People Also Watch

105.71
NTRS
+4.01%
357.39
EG
-0.27%
208.20
AIZ
+1.69%
23.79
AMTM
+2.54%

FAQ

What Is the Teleflex (TFX) Stock Price Today?

The Teleflex stock price today is 177.68

What Stock Exchange Does Teleflex Trade On?

Teleflex is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Teleflex?

The stock symbol for Teleflex is "TFX."

Does Teleflex Pay Dividends? What’s The Current Dividend Yield?

The Teleflex dividend yield is 0.76%.

What Is the Teleflex Market Cap?

As of today, Teleflex market cap is 8.23B.

What is Teleflex Earnings Per Share?

The Teleflex EPS is 5.05.

What Is the Next Teleflex Earnings Date?

Teleflex will release its next earnings report on Feb 20, 2025.

From a Technical Analysis Perspective, Is TFX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.